![Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus](https://www.mdpi.com/cells/cells-08-00963/article_deploy/html/images/cells-08-00963-g001.png)
Cells | Free Full-Text | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
![Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram](https://www.researchgate.net/publication/340506074/figure/fig1/AS:880625905049601@1586968985059/Early-and-delayed-events-in-interferon-signaling-The-recognition-of-viruses-by-cells.png)
Early and delayed events in interferon signaling. The recognition of... | Download Scientific Diagram
![Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine](https://lupus.bmj.com/content/lupusscimed/6/1/e000270/F2.large.jpg)
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
![Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram](https://www.researchgate.net/publication/331217974/figure/fig5/AS:960350530830337@1605976817399/Pathways-of-interferon-receptor-inhibitor-of-nuclear-factor-kappa-B-kinase-subunit.png)
Pathways of interferon receptor, inhibitor of nuclear factor kappa-B... | Download Scientific Diagram
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases | PLOS ONE
![Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41590-019-0466-2/MediaObjects/41590_2019_466_Fig1_HTML.png)
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
![A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/asset/d41cf116-5ce2-4dfa-b26f-a01f3e331c97/gr1.jpg)
A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19 - eClinicalMedicine
![IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases](https://pub.mdpi-res.com/ijms/ijms-22-11286/article_deploy/html/images/ijms-22-11286-g001.png?1634786376)
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
![Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00018-020-03671-z/MediaObjects/18_2020_3671_Fig1_HTML.png)
Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway | SpringerLink
![An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine](https://www.thelancet.com/cms/attachment/fa9a0aca-0d97-4115-b727-5009ec1660c4/gr2_lrg.jpg)
An open-label, randomized trial of the combination of IFN-κ plus TFF2 with standard care in the treatment of patients with moderate COVID-19 - eClinicalMedicine
![Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine](https://lupus.bmj.com/content/lupusscimed/6/1/e000270/F1.large.jpg)